Venlafaxine hydrochloride NDC 33342-196

NDC codes

FDA NDC Directory

Product NDC (as listed)33342-196Labeler and product segments. Claims need a package NDC.

Product NDC at billing width33342-0196Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
33342-196-07	33342019607	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (33342-196-07)Marketed from Oct 6, 2017
33342-196-10	33342019610	90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (33342-196-10)Marketed from Aug 14, 2018
33342-196-11	33342019611	100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (33342-196-11)Marketed from Aug 14, 2018
33342-196-15	33342019615	500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (33342-196-15)Marketed from Oct 6, 2017

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Venlafaxine hydrochloride
Generic name (nonproprietary): venlafaxine hydrochloride
Active ingredients: Venlafaxine hydrochloride — 150 mg/1
Dosage form: Capsule, Extended release
Route: Oral
Labeler: Macleods Pharmaceuticals Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 204889
Marketing start: Oct 6, 2017
Listing expires: Dec 31, 2027
Other FDA classes: Norepinephrine Uptake Inhibitors (Mechanism)Serotonin Uptake Inhibitors (Mechanism)
Identifiers: Product ID 33342-196_f913aca4-ac1e-475d-80ed-f48c7c2666c5SPL ID f913aca4-ac1e-475d-80ed-f48c7c2666c5SPL set ID 3e51f786-3691-4ec4-836b-7f2c9a385aa7RxCUI 313581, 313583, 313585UNII 7D7RX5A8MOUPC 0333342195074, 0333342196071, 0333342194152, 0333342196156, 0333342194077
Pharmacologic class: Serotonin and Norepinephrine Reuptake Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N433342019607 followed by a unit qualifier and the quantity

Package 33342-0196-07. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 15, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Venlafaxine hydrochloride extended-release capsules are indicated in adults for the treatment of: • Major Depressive Disorder (MDD) [see Clinical Studies ( 14.1 )] • Generalized Anxiety Disorder (GAD) [see Clinical Studies ( 14.2 )] • Social Anxiety Disorder (SAD) [see Clinical Studies ( 14.3 )] • Panic Disorder (PD) [see Clinical Studies ( 14.4 )] Venlafaxine hydrochloride extended-release capsules are a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of adults with: • Major Depressive Disorder (MDD) ( 1 ) • Generalized Anxiety Disorder (GAD) ( 1 ) • Social Anxiety Disorder (SAD) ( 1 ) • Panic Disorder (PD) ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 204889

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 204889
Product	Strength	Form · route	Labeler	Product NDC
Venlafaxine hydrochloride	Venlafaxine hydrochloride 75 mg/1	Capsule, Extended releaseOral	Macleods Pharmaceuticals Limited	33342-195
Venlafaxine hydrochloride	Venlafaxine hydrochloride 37.5 mg/1	Capsule, Extended releaseOral	Macleods Pharmaceuticals Limited	33342-194